BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17433452)

  • 1. Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance.
    Fateeva A; Eddy K; Chen S
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin Lymphoma Cell Lines and Tissues Express mGluR5: A Potential Link to Ophelia Syndrome and Paraneoplastic Neurological Disease.
    Schnell S; Knierim E; Bittigau P; Kreye J; Hauptmann K; Hundsdoerfer P; Morales-Gonzalez S; Schuelke M; Nikolaus M
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment.
    Blaylock RL
    Surg Neurol Int; 2019; 10():199. PubMed ID: 31768279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond.
    Schaefer T; Lengerke C
    Oncogene; 2020 Jan; 39(2):278-292. PubMed ID: 31477842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma.
    Wei L; He F; Zhang W; Chen W; Yu B
    Biol Res; 2018 Aug; 51(1):26. PubMed ID: 30124166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Metabotropic Glutamate Receptor 4 Suppresses Proliferation and Promotes Apoptosis With Inhibition of Gli-1 in Human Glioblastoma Cells.
    Zhang Z; Zheng X; Luan Y; Liu Y; Li X; Liu C; Lu H; Chen X; Liu Y
    Front Neurosci; 2018; 12():320. PubMed ID: 29867331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation.
    Scholler P; Nevoltris D; de Bundel D; Bossi S; Moreno-Delgado D; Rovira X; Møller TC; El Moustaine D; Mathieu M; Blanc E; McLean H; Dupuis E; Mathis G; Trinquet E; Daniel H; Valjent E; Baty D; Chames P; Rondard P; Pin JP
    Nat Commun; 2017 Dec; 8(1):1967. PubMed ID: 29213077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.
    Pereira MSL; Klamt F; Thomé CC; Worm PV; de Oliveira DL
    Oncotarget; 2017 Mar; 8(13):22279-22298. PubMed ID: 28212543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate and its receptors in cancer.
    Stepulak A; Rola R; Polberg K; Ikonomidou C
    J Neural Transm (Vienna); 2014 Aug; 121(8):933-44. PubMed ID: 24610491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
    Ganor Y; Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):983-1006. PubMed ID: 24584970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could MDMA Promote Stemness Characteristics in Mouse Embryonic Stem Cells via mGlu5 Metabotropic Glutamate Receptors?
    Meamar R; Karamali F; Mousavi SA; Baharvand H; Nasr-Esfahani MH
    Cell J; 2012; 14(3):185-92. PubMed ID: 23508940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
    Martino JJ; Wall BA; Mastrantoni E; Wilimczyk BJ; La Cava SN; Degenhardt K; White E; Chen S
    Oncogene; 2013 Sep; 32(37):4366-76. PubMed ID: 23085756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways: dysregulated glutamatergic signaling pathways in cancer.
    Prickett TD; Samuels Y
    Clin Cancer Res; 2012 Aug; 18(16):4240-6. PubMed ID: 22648273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.
    DeBerardinis RJ; Cheng T
    Oncogene; 2010 Jan; 29(3):313-24. PubMed ID: 19881548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glutamate receptor subunits in human cancers.
    Stepulak A; Luksch H; Gebhardt C; Uckermann O; Marzahn J; Sifringer M; Rzeski W; Staufner C; Brocke KS; Turski L; Ikonomidou C
    Histochem Cell Biol; 2009 Oct; 132(4):435-45. PubMed ID: 19526364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein-coupled receptors and melanoma.
    Lee HJ; Wall B; Chen S
    Pigment Cell Melanoma Res; 2008 Aug; 21(4):415-28. PubMed ID: 18582227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptors in glial cells.
    D'Antoni S; Berretta A; Bonaccorso CM; Bruno V; Aronica E; Nicoletti F; Catania MV
    Neurochem Res; 2008 Dec; 33(12):2436-43. PubMed ID: 18438710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptors: new targets for the control of tumor growth?
    Nicoletti F; Arcella A; Iacovelli L; Battaglia G; Giangaspero F; Melchiorri D
    Trends Pharmacol Sci; 2007 May; 28(5):206-13. PubMed ID: 17433452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors: beyond the regulation of synaptic transmission.
    Nicoletti F; Battaglia G; Storto M; Ngomba RT; Iacovelli L; Arcella A; Gradini R; Sale P; Rampello L; De Vita T; Di Marco R; Melchiorri D; Bruno V
    Psychoneuroendocrinology; 2007 Aug; 32 Suppl 1():S40-5. PubMed ID: 17651904
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.